Site for Reliance COPD Exacerbations stage 2
RofLumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Chronic Obstructive Pulmonary Disease (COPD)
Study Purpose
RELIANCE is a study comparing two drugs. We are trying to learn which one works better, and is better tolerated in people with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease. We want to compare these drugs in a real world setting.Today, doctors use both Roflumilast and Azithromycin to treat COPD. Research shows that people who take Roflumilast or Azithromycin go to the hospital less often for COPD attacks. We want to see if Azithromycin is as good as Roflumilast for preventing COPD attacks and thereby decrease hospital visits.
Who Can Participate
Age: 40 and older
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: SITE00000081
- StudyID: SITE00000081
- ClinicalTrials.gov: NCT04069312
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422